Increased FAT10 expression is related to poor prognosis in pancreatic ductal adenocarcinoma

Tumor Biology

Volumn 35, Issue 6, 2014, Pages 5167-5171

  Sun, Guo Hui ^a   Liu, Ying Di ^a   Yu, Guo ^a   Li, Nan ^a   Sun, Xiao ^a   Yang, Jing ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Biomarker; FAT10; PDAC; Prognosis

Indexed keywords

FAT10 PROTEIN; MESSENGER RNA; UBIQUITIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; FEMALE; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; TUMOR DIFFERENTIATION;

ADULT; AGED; CARCINOMA, PANCREATIC DUCTAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; UBIQUITINS;

EID: 84904768556     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-1670-1     Document Type: Article

References (15)

1. Jimeno A, Hidalgo M. Molecular biomarkers: their increasing role in the diagnosis, characterization, and therapy guidance in pancreatic cancer. Mol Cancer Ther. 2006;5:787-96. doi:10.1158/1535-7163.MCT-06-0005. (Pubitemid 43724577)
2. Ansari D, Rosendahl A, Elebro J, Andersson R. Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer. Br J Surg. 2011;98:1041-55. doi:10.1002/bjs.7574.
3. Jamieson NB, Carter CR, McKay CJ, Oien KA. Tissue biomarkers for prognosis in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis. Clin Cancer Res. 2011;17(10):3316-31. doi:10.1158/1078-0432.CCR- 10-3284.
4. Winter JM, Yeo CJ, Brody JR. Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer. J Surg Oncol. 2013;107(1):15-22. doi:10.1002/jso.23192.
5. Fan W, Cai W, Parimoo S, Schwarz DC, Lennon GG, Weissman SM. Identification of seven new human MHC class I region genes around the HLA-F locus. Immunogenetics. 1996;44:97-103. (Pubitemid 26164207)
6. Bates EE, Ravel O, Dieu MC, Ho S, Guret C, Bridon JM, et al. Identification and analysis of a novel member of the ubiquitin family expressed in dendritic cells and mature B cells. Eur J Immunol. 1997;27:2471-7. doi:10.1002/eji.1830271002. (Pubitemid 27453832)
7. Raasi S, Schmidtke G, Groettrup M. The ubiquitin-like protein FAT10 forms covalent conjugates and induces apoptosis. J Biol Chem. 2001;276(38):35334-43. doi:10.1074/jbc.M105139200.
8. Lee CG, Ren J, Cheong IS, Ban KH, Ooi LL, Yong Tan S, et al. Expression of the FAT10 gene is highly upregulated in hepatocellular carcinoma and other gastrointestinal and gynecological cancers. Oncogene. 2003;22:2592-603. doi:10.1038/sj.onc.1206337. (Pubitemid 36605607)
9. Lukasiak S, Schiller C, Oehlschlaeger P, Schmidtke G, Krause P, Legler DF, et al. Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon. Oncogene. 2008;27:6068-74. doi:10.1038/onc.2008.201.
10. Yuan R, Jiang C, Hong K, Yu X, Wu L, Liu T, et al. Genetic variation in the Fat10 gene is associated with risk of hepatocellular carcinoma in a Chinese population. Asian Pac J Cancer Prev. 2011;12:2117-22.
11. Liu L, Dong Z, Liang J, Cao C, Sun J, Ding Y, et al. As an independent prognostic factor, FAT10 promotes hepatitis B virusrelated hepatocellular carcinoma progression via Akt/GSK3β pathway. Oncogene. 2013. doi:10.1038/onc.2013.236.
12. Ji F, Jin X, Jiao CH, Xu QW, Wang ZW, Chen YL. FAT10 level in human gastric cancer and its relation with mutant p53 level, lymph node metastasis, and TNM staging. World J Gastroenterol. 2009;15:2228-33. doi:10.3748/wjg.15. 2228.
13. Yuan J, Tu Y, Mao X, He S, Wang L, Fu G, et al. Increased expression of FAT10 is correlated with progression and prognosis of human glioma. Pathol Oncol Res. 2012;18:833-9.
14. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277-300. doi:10.3322/caac.20073.
15. Cameron JL, Riall TS, Coleman J, Belcher KA. One thousand consecutive pancreaticoduodenectomies. Ann Surg. 2006;244:10-5. doi:10.1097/01.sla. 0000217673.04165.ea. (Pubitemid 44297442)